Top compounds associated with response to RP11-302B13.5


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Axitinib CTRPv2 pan-cancer AAC -0.035 0.3
mRNA Merck60 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA apicidin CTRPv2 pan-cancer AAC -0.032 0.3
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.047 0.3
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.037 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA itraconazole CTRPv2 pan-cancer AAC -0.039 0.3
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.056 0.3
Download CSV